Related Experiment Videos
[Antibiotic resistance of Helicobacter pylori]
Fen Wang1, Shou-rong Shen, Jian-dang Zhou
1Department of Gastroenterology, Third Xiangya Hospital, Central South University, Changsha 410013, China.
Objective:
To examine the infection and bacteria resistance of Helicobacter pylori (H.pylori) to clarithromycin and furazolidone,to determine whether the antibiotic resistance is primary or secondary, and to decide if a new H.pylori infection plays a role in eradication failures.
Methods:
Twenty one H.pylori had been isolated from human biopsy specimens, and antimicrobial susceptibility testing was performed. DNA fingerprints were generated using random amplification polymorphic DNA (RAPD) to determine the identity of H.pylori before and after the eradication therapy.
Results:
Eight bacteria resisted against clarithromycin, and one against furazolidone, with the resistant rates 38.1% and 4.8% respectively. The number of primary antibiotic resistance, secondary resistance and new infection was 1 for each.
Conclusion:
Resistance to clarithromycin is more common compared with that to furazolidone. Development of primary and secondary resistance to clarithromycin occurs as a rule in eradication failures. New H.pylori infection plays a role in eradication failures.
Related Concept Videos
00:46Genomic DNA in Prokaryotes
Genomic Diversity in Bacteria
Although bacterial genomes are much...
01:30Development of Antibiotic Resistance
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
00:57Antibiotic Selection
01:24Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.